Carisoprodol

• CAT Number: R009907
• CAS Number: 78-44-4
• Molecular Formula: C12H24N2O4
• Molecular Weight: 260.33
• Purity: ≥95%
• Synonyms: N-(1-Methylethyl)carbamic Acid 2-[[(Aminocarbonyl)oxy]methyl]-2-methylpentyl Ester; Domarax; N-Isopropyl-2-methyl-2-propyl-1,3-propanediol Dicarbamate; Flexal; Isomeprobamate; NIH 10966; NSC 172124; Somalgit; Stialgin
• Storage: -20°C
• IUPAC Name: [2-(carbamoyloxymethyl)-2-methylpentyl] N-propan-2-ylcarbamate
• InChI: InChI=1S/C12H24N2O4/c1-5-6-12(4,7-17-10(13)15)8-18-11(16)14-9(2)3/h9H,5-8H2,1-4H3,(H2,13,15)(H,14,16)
• InChIKey: OFZCIYFFPZCNJE-UHFFFAOYSA-N
• SMILES: CC(C)NC(OCC(CCC)(C)COC(N)=O)=O

Carisoprodol(CAT: R009907) is a centrally acting skeletal muscle relaxant widely studied in pharmacology and neuroscience. It functions by modulating GABAA​ receptor–mediated inhibitory neurotransmission, leading to muscle relaxation and sedative effects. In clinical settings, Carisoprodol is used for the short-term relief of acute musculoskeletal pain, though its potential for dependence and abuse has made it a focus of safety and toxicological research. As it is metabolized to meprobamate, an anxiolytic agent, Carisoprodol is also studied for its role in CNS pharmacodynamics, drug metabolism, and receptor modulation.